BioCryst Pharmaceuticals
BCRX
#4790
Rank
A$2.38 B
Marketcap
$11.50
Share price
2.60%
Change (1 day)
47.93%
Change (1 year)

BioCryst Pharmaceuticals (BCRX) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : A$1.47 Billion

According to BioCryst Pharmaceuticals 's latest financial reports the company's total liabilities are A$1.47 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

BioCryst Pharmaceuticals - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31A$1.42 B15.01%
2022-12-31A$1.24 B29.44%
2021-12-31A$0.95 B108.28%
2020-12-31A$0.46 B135.21%
2019-12-31A$0.19 B41.26%
2018-12-31A$0.13 B14.47%
2017-12-31A$0.12 B-1.16%
2016-12-31A$0.12 B19.53%
2015-12-31A$0.10 B36.92%
2014-12-31A$74.82 M33.51%
2013-12-31A$56.04 M0.6%
2012-12-31A$55.7 M-15.25%
2011-12-31A$65.73 M51.95%
2010-12-31A$43.26 M-30.51%
2009-12-31A$62.25 M14.78%
2008-12-31A$54.23 M-39.06%
2007-12-31A$89 M48.23%
2006-12-31A$60.04 M7.66%
2005-12-31A$55.77 M1276.96%
2004-12-31A$4.05 M82.64%
2003-12-31A$2.21 M6.61%
2002-12-31A$2.08 M-53.49%
2001-12-31A$4.47 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
A$1.34 B-8.78%๐Ÿ‡บ๐Ÿ‡ธ USA
A$3.65 B 147.85%๐Ÿ‡บ๐Ÿ‡ธ USA
A$2.08 M-99.86%๐Ÿ‡บ๐Ÿ‡ธ USA
A$3.45 B 134.46%๐Ÿ‡บ๐Ÿ‡ธ USA
A$54.33 B 3,586.33%๐Ÿ‡บ๐Ÿ‡ธ USA
A$57.24 M-96.12%๐Ÿ‡บ๐Ÿ‡ธ USA
A$91.65 B 6,118.29%๐Ÿ‡ฌ๐Ÿ‡ง UK
A$1.73 B 17.44%๐Ÿ‡บ๐Ÿ‡ธ USA
A$23.94 M-98.38%๐Ÿ‡บ๐Ÿ‡ธ USA